{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:48:23Z","timestamp":1761821303455,"version":"3.40.3"},"publisher-location":"Vienna","reference-count":82,"publisher":"Springer Vienna","isbn-type":[{"type":"print","value":"9783709115107"},{"type":"electronic","value":"9783709115114"}],"license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/978-3-7091-1511-4_20","type":"book-chapter","created":{"date-parts":[[2013,4,6]],"date-time":"2013-04-06T05:43:12Z","timestamp":1365226992000},"page":"405-419","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Neuronal Forms of Gaucher Disease"],"prefix":"10.1007","author":[{"given":"Einat B.","family":"Vitner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony H.","family":"Futerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,3,7]]},"reference":[{"issue":"10","key":"20_CR00201","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1002\/mds.23109","volume":"25","author":"A Alonso-Canovas","year":"2010","unstructured":"Alonso-Canovas A, Katschnig P, Tucci A, Carecchio M, Wood NW, Edwards M et al (2010) Atypical parkinsonism with apraxia and supranuclear gaze abnormalities in type 1 Gaucher disease. Expanding the spectrum: case report and literature review. Mov Disord 25(10):1506\u20131509","journal-title":"Mov Disord"},{"issue":"4","key":"20_CR00202","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1089\/gte.1998.2.297","volume":"2","author":"J Azuri","year":"1998","unstructured":"Azuri J, Elstein D, Lahad A, Abrahamov A, Hadas-Halpern I, Zimran A (1998) Asymptomatic Gaucher disease implications for large-scale screening. Genet Test 2(4):297\u2013299","journal-title":"Genet Test"},{"issue":"10","key":"20_CR00203","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/mds.21399","volume":"22","author":"C Balducci","year":"2007","unstructured":"Balducci C, Pierguidi L, Persichetti E, Parnetti L, Sbaragli M, Tassi C et al (2007) Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson\u02bcs disease. Mov Disord 22(10):1481\u20131484","journal-title":"Mov Disord"},{"issue":"2","key":"20_CR00204","first-page":"205","volume":"10","author":"V Barak","year":"1999","unstructured":"Barak V, Acker M, Nisman B, Kalickman I, Abrahamov A, Zimran A et al (1999) Cytokines in Gaucher\u02bcs disease. Eur Cytokine Netw 10(2):205\u2013210","journal-title":"Eur Cytokine Netw"},{"issue":"6","key":"20_CR00205","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1001\/archneur.59.6.999","volume":"59","author":"D Berg","year":"2002","unstructured":"Berg D, Roggendorf W, Schroder U, Klein R, Tatschner T, Benz P et al (2002) Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 59(6):999\u20131005","journal-title":"Arch Neurol"},{"issue":"3","key":"20_CR00206","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.bcmd.2005.07.005","volume":"35","author":"E Beutler","year":"2005","unstructured":"Beutler E, Gelbart T, Scott CR (2005) Hematologically important mutations: Gaucher disease. Blood Cells Mol Dis 35(3):355\u2013364","journal-title":"Blood Cells Mol Dis"},{"issue":"3","key":"20_CR00207","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10545-008-0832-y","volume":"31","author":"M Biegstraaten","year":"2008","unstructured":"Biegstraaten M, van Schaik IN, Aerts JM, Hollak CE (2008) \u02bbNon-neuronopathic\u02bc Gaucher disease reconsidered. Prevalence of neurological manifestations in a Dutch cohort of type I Gaucher disease patients and a systematic review of the literature. J Inherit Metab Dis 31(3):337\u2013349","journal-title":"J Inherit Metab Dis"},{"issue":"39","key":"20_CR00208","doi-asserted-by":"publisher","first-page":"29052","DOI":"10.1074\/jbc.M705005200","volume":"282","author":"B Brumshtein","year":"2007","unstructured":"Brumshtein B, Greenblatt HM, Butters TD, Shaaltiel Y, Aviezer D, Silman I et al (2007) Crystal structures of complexes of N-butyl- and N-nonyl-deoxynojirimycin bound to acid beta-glucosidase: insights into the mechanism of chemical chaperone action in Gaucher disease. J Biol Chem 282(39):29052\u201329058","journal-title":"J Biol Chem"},{"issue":"2","key":"20_CR00209","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/jnnp.2006.111518","volume":"79","author":"JL Capablo","year":"2008","unstructured":"Capablo JL, Saenz de Cabezon A, Fraile J, Alfonso P, Pocovi M, Giraldo P (2008) Neurological evaluation of patients with Gaucher disease diagnosed as type 1. J Neurol Neurosurg Psychiatry 79(2):219\u2013222","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"20_CR002010","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/BF00690463","volume":"65","author":"NG Conradi","year":"1984","unstructured":"Conradi NG, Sourander P, Nilsson O, Svennerholm L, Erikson A (1984) Neuropathology of the Norrbottnian type of Gaucher disease. Morphological and biochemical studies. Acta Neuropathol 65(2):99\u2013109","journal-title":"Acta Neuropathol"},{"issue":"4","key":"20_CR002011","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/BF00687792","volume":"75","author":"NG Conradi","year":"1988","unstructured":"Conradi NG, Kalimo H, Sourander P (1988) Reactions of vessel walls and brain parenchyma to the accumulation of Gaucher cells in the Norrbottnian type (type III) of Gaucher disease. Acta Neuropathol 75(4):385\u2013390","journal-title":"Acta Neuropathol"},{"issue":"2","key":"20_CR002012","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/BF00293959","volume":"82","author":"N Conradi","year":"1991","unstructured":"Conradi N, Kyllerman M, Mansson JE, Percy AK, Svennerholm L (1991) Late-infantile Gaucher disease in a child with myoclonus and bulbar signs: neuropathological and neurochemical findings. Acta Neuropathol 82(2):152\u2013157","journal-title":"Acta Neuropathol"},{"issue":"4","key":"20_CR002013","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0950-3536(97)80033-9","volume":"10","author":"TM Cox","year":"1997","unstructured":"Cox TM, Schofield JP (1997) Gaucher\u02bcs disease: clinical features and natural history. Baillieres Clin Haematol 10(4):657\u2013689","journal-title":"Baillieres Clin Haematol"},{"issue":"6","key":"20_CR002014","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/ana.22400","volume":"69","author":"V Cullen","year":"2011","unstructured":"Cullen V, Sardi SP, Ng J, Xu YH, Sun Y, Tomlinson JJ et al (2011) Acid beta-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter alpha-synuclein processing. Ann Neurol 69(6):940\u2013953","journal-title":"Ann Neurol"},{"issue":"7","key":"20_CR002015","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/sj.embor.embor873","volume":"4","author":"H Dvir","year":"2003","unstructured":"Dvir H, Harel M, McCarthy AA, Toker L, Silman I, Futerman AH et al (2003) X-ray structure of human acid-beta-glucosidase, the defective enzyme in Gaucher disease. EMBO Rep 4(7):704\u2013709","journal-title":"EMBO Rep"},{"issue":"2","key":"20_CR002016","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/mds.20766","volume":"21","author":"MJ Eblan","year":"2006","unstructured":"Eblan MJ, Nguyen J, Ziegler SG, Lwin A, Hanson M, Gallardo M et al (2006) Glucocerebrosidase mutations are also found in subjects with early-onset parkinsonism from Venezuela. Mov Disord 21(2):282\u2013283","journal-title":"Mov Disord"},{"issue":"44","key":"20_CR002017","doi-asserted-by":"publisher","first-page":"17483","DOI":"10.1073\/pnas.0708086104","volume":"104","author":"IB Enquist","year":"2007","unstructured":"Enquist IB, Lo Bianco C, Ooka A, Nilsson E, Mansson JE, Ehinger M et al (2007) Murine models of acute neuronopathic Gaucher disease. Proc Natl Acad Sci USA 104(44):17483\u201317488","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"20_CR002018","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1093\/hmg\/ddp061","volume":"18","author":"T Farfel-Becker","year":"2009","unstructured":"Farfel-Becker T, Vitner E, Dekel H, Leshem N, Enquist IB, Karlsson S et al (2009) No evidence for activation of the unfolded protein response in neuronopathic models of Gaucher disease. Hum Mol Genet 18(8):1482\u20131488","journal-title":"Hum Mol Genet"},{"issue":"6","key":"20_CR002019","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1242\/dmm.008185","volume":"4","author":"T Farfel-Becker","year":"2011","unstructured":"Farfel-Becker T, Vitner EB, Futerman AH (2011a) Animal models for Gaucher disease research. Dis Model Mech 4(6):746\u2013752","journal-title":"Dis Model Mech"},{"issue":"7","key":"20_CR002020","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1093\/hmg\/ddr019","volume":"20","author":"T Farfel-Becker","year":"2011","unstructured":"Farfel-Becker T, Vitner EB, Pressey SN, Eilam R, Cooper JD, Futerman AH (2011b) Spatial and temporal correlation between neuron loss and neuroinflammation in a mouse model of neuronopathic Gaucher disease. Hum Mol Genet 20(7):1375\u20131386","journal-title":"Hum Mol Genet"},{"issue":"4","key":"20_CR002021","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1152\/physrev.00013.2002","volume":"82","author":"M Fill","year":"2002","unstructured":"Fill M, Copello JA (2002) Ryanodine receptor calcium release channels. Physiol Rev 82(4):893\u2013922","journal-title":"Physiol Rev"},{"issue":"Pt 2","key":"20_CR002022","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1042\/bj2800295","volume":"280","author":"AH Futerman","year":"1991","unstructured":"Futerman AH, Pagano RE (1991) Determination of the intracellular sites and topology of glucosylceramide synthesis in rat liver. Biochem J 280(Pt 2):295\u2013302","journal-title":"Biochem J"},{"issue":"3","key":"20_CR002023","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.tips.2004.01.004","volume":"25","author":"AH Futerman","year":"2004","unstructured":"Futerman AH, Sussman JL, Horowitz M, Silman I, Zimran A (2004) New directions in the treatment of Gaucher disease. Trends Pharmacol Sci 25(3):147\u2013151","journal-title":"Trends Pharmacol Sci"},{"issue":"24","key":"20_CR002024","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1212\/01.wnl.0000304039.11891.29","volume":"70","author":"Z Gan-Or","year":"2008","unstructured":"Gan-Or Z, Giladi N, Rozovski U, Shifrin C, Rosner S, Gurevich T et al (2008) Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset. Neurology 70(24):2277\u20132283","journal-title":"Neurology"},{"key":"20_CR002025","unstructured":"Gaucher PCE (1882) De l\u2019Epith\u00e9lioma Primitif de la Rate: Hypertrophie Idiopathique de la Rate sans Leuce\u00b4mie, Ph.D. thesis. University of Paris, Paris"},{"key":"20_CR002026","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4419-6741-1_1","volume":"688","author":"CR Gault","year":"2010","unstructured":"Gault CR, Obeid LM, Hannun YA (2010) An overview of sphingolipid metabolism: from synthesis to breakdown. Adv Exp Med Biol 688:1\u201323","journal-title":"Adv Exp Med Biol"},{"issue":"12","key":"20_CR002027","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1136\/jmg.2004.024455","volume":"41","author":"O Goker-Alpan","year":"2004","unstructured":"Goker-Alpan O, Schiffmann R, LaMarca ME, Nussbaum RL, McInerney-Leo A, Sidransky E (2004) Parkinsonism among Gaucher disease carriers. J Med Genet 41(12):937\u2013940","journal-title":"J Med Genet"},{"issue":"10","key":"20_CR002028","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1001\/archneur.65.10.1353","volume":"65","author":"O Goker-Alpan","year":"2008","unstructured":"Goker-Alpan O, Lopez G, Vithayathil J, Davis J, Hallett M, Sidransky E (2008) The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations. Arch Neurol 65(10):1353\u20131357","journal-title":"Arch Neurol"},{"issue":"5","key":"20_CR002029","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00401-010-0741-7","volume":"120","author":"O Goker-Alpan","year":"2010","unstructured":"Goker-Alpan O, Stubblefield BK, Giasson BI, Sidransky E (2010) Glucocerebrosidase is present in alpha-synuclein inclusions in Lewy body disorders. Acta Neuropathol 120(5):641\u2013649","journal-title":"Acta Neuropathol"},{"issue":"3","key":"20_CR002030","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.bcmd.2006.02.004","volume":"36","author":"A Halperin","year":"2006","unstructured":"Halperin A, Elstein D, Zimran A (2006) Increased incidence of Parkinson disease among relatives of patients with Gaucher disease. Blood Cells Mol Dis 36(3):426\u2013428","journal-title":"Blood Cells Mol Dis"},{"issue":"10","key":"20_CR002031","first-page":"2776","volume":"39","author":"M Henkart","year":"1980","unstructured":"Henkart M (1980) Identification and function of intracellular calcium stores in neurons. Fed Proc 39(10):2776\u20132777","journal-title":"Fed Proc"},{"issue":"2","key":"20_CR002032","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1006\/bcmd.1997.0137","volume":"23","author":"CE Hollak","year":"1997","unstructured":"Hollak CE, Evers L, Aerts JM, van Oers MH (1997) Elevated levels of M-CSF, sCD14 and IL8 in type 1 Gaucher disease. Blood Cells Mol Dis 23(2):201\u2013212","journal-title":"Blood Cells Mol Dis"},{"issue":"4","key":"20_CR002033","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3346\/jkms.2006.21.4.733","volume":"21","author":"YB Hong","year":"2006","unstructured":"Hong YB, Kim EY, Jung SC (2006) Upregulation of proinflammatory cytokines in the fetal brain of the Gaucher mouse. J Korean Med Sci 21(4):733\u2013738","journal-title":"J Korean Med Sci"},{"issue":"1","key":"20_CR002034","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/humu.1380030102","volume":"3","author":"M Horowitz","year":"1994","unstructured":"Horowitz M, Zimran A (1994) Mutations causing Gaucher disease. Hum Mutat 3(1):1\u201311","journal-title":"Hum Mutat"},{"issue":"2","key":"20_CR002035","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1365-2141.2004.05351.x","volume":"129","author":"M Jmoudiak","year":"2005","unstructured":"Jmoudiak M, Futerman AH (2005) Gaucher disease: pathological mechanisms and modern management. Br J Haematol 129(2):178\u2013188","journal-title":"Br J Haematol"},{"issue":"2","key":"20_CR002036","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.neulet.2009.01.029","volume":"452","author":"K Kalinderi","year":"2009","unstructured":"Kalinderi K, Bostantjopoulou S, Paisan-Ruiz C, Katsarou Z, Hardy J, Fidani L (2009) Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece. Neurosci Lett 452(2):87\u201389","journal-title":"Neurosci Lett"},{"issue":"1","key":"20_CR002037","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0006-291X(75)90286-7","volume":"67","author":"JN Kanfer","year":"1975","unstructured":"Kanfer JN, Legler G, Sullivan J, Raghavan SS, Mumford RA (1975) The Gaucher mouse. Biochem Biophys Res Commun 67(1):85\u201390","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"20_CR002038","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/ana.410200208","volume":"20","author":"EM Kaye","year":"1986","unstructured":"Kaye EM, Ullman MD, Wilson ER, Barranger JA (1986) Type 2 and type 3 Gaucher disease: a morphological and biochemical study. Ann Neurol 20(2):223\u2013230","journal-title":"Ann Neurol"},{"issue":"6","key":"20_CR002039","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1242\/dmm.008615","volume":"4","author":"KJ Kinghorn","year":"2011","unstructured":"Kinghorn KJ (2011) Pathological looping in the synucleinopathies: investigating the link between Parkinson\u02bcs disease and Gaucher disease. Dis Model Mech 4(6):713\u2013715","journal-title":"Dis Model Mech"},{"issue":"12","key":"20_CR002040","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1002\/mds.23213","volume":"25","author":"S Kono","year":"2010","unstructured":"Kono S, Ouchi Y, Terada T, Ida H, Suzuki M, Miyajima H (2010) Functional brain imaging in glucocerebrosidase mutation carriers with and without parkinsonism. Mov Disord 25(12):1823\u20131829","journal-title":"Mov Disord"},{"issue":"31","key":"20_CR002041","doi-asserted-by":"publisher","first-page":"21673","DOI":"10.1074\/jbc.274.31.21673","volume":"274","author":"E Korkotian","year":"1999","unstructured":"Korkotian E, Schwarz A, Pelled D, Schwarzmann G, Segal M, Futerman AH (1999) Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons. J Biol Chem 274(31):21673\u201321678","journal-title":"J Biol Chem"},{"issue":"1","key":"20_CR002042","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/0003-9861(88)90467-5","volume":"260","author":"G Legler","year":"1988","unstructured":"Legler G, Bieberich E (1988) Active site directed inhibition of a cytosolic beta-glucosidase from calf liver by bromoconduritol B epoxide and bromoconduritol F. Arch Biochem Biophys 260(1):437\u2013442","journal-title":"Arch Biochem Biophys"},{"issue":"26","key":"20_CR002043","doi-asserted-by":"publisher","first-page":"23594","DOI":"10.1074\/jbc.M300212200","volume":"278","author":"E Lloyd-Evans","year":"2003","unstructured":"Lloyd-Evans E, Pelled D, Riebeling C, Bodennec J, de-Morgan A, Waller H et al (2003) Glucosylceramide and glucosylsphingosine modulate calcium mobilization from brain microsomes via different mechanisms. J Biol Chem 278(26):23594\u201323599","journal-title":"J Biol Chem"},{"issue":"6","key":"20_CR002044","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.neuro.2009.06.009","volume":"30","author":"AB Manning-Bog","year":"2009","unstructured":"Manning-Bog AB, Schule B, Langston JW (2009) Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: a biological link between Gaucher disease and parkinsonism. Neurotoxicology 30(6):1127\u20131132","journal-title":"Neurotoxicology"},{"issue":"2","key":"20_CR002045","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.neulet.2009.12.007","volume":"469","author":"XY Mao","year":"2010","unstructured":"Mao XY, Burgunder JM, Zhang ZJ, An XK, Zhang JH, Yang Y et al (2010) Association between GBA L444P mutation and sporadic Parkinson\u02bcs disease from Mainland China. Neurosci Lett 469(2):256\u2013259","journal-title":"Neurosci Lett"},{"issue":"1","key":"20_CR002046","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","volume":"146","author":"JR Mazzulli","year":"2011","unstructured":"Mazzulli JR, Xu YH, Sun Y, Knight AL, McLean PJ, Caldwell GA et al (2011) Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 146(1):37\u201352","journal-title":"Cell"},{"issue":"10","key":"20_CR002047","doi-asserted-by":"publisher","first-page":"6387","DOI":"10.1021\/cr2002917","volume":"111","author":"AH Merrill Jr","year":"2011","unstructured":"Merrill AH Jr (2011) Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics. Chem Rev 111(10):6387\u20136422","journal-title":"Chem Rev"},{"issue":"3","key":"20_CR002048","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0959-4388(97)80061-X","volume":"7","author":"K Mikoshiba","year":"1997","unstructured":"Mikoshiba K (1997) The InsP3 receptor and intracellular Ca2+ signaling. Curr Opin Neurobiol 7(3):339\u2013345","journal-title":"Curr Opin Neurobiol"},{"issue":"9","key":"20_CR002049","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1172\/JCI0214530","volume":"109","author":"H Mizukami","year":"2002","unstructured":"Mizukami H, Mi Y, Wada R, Kono M, Yamashita T, Liu Y et al (2002) Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage. J Clin Invest 109(9):1215\u20131221","journal-title":"J Clin Invest"},{"issue":"53","key":"20_CR002050","doi-asserted-by":"publisher","first-page":"42105","DOI":"10.1074\/jbc.M110.172098","volume":"285","author":"MN Offman","year":"2010","unstructured":"Offman MN, Krol M, Silman I, Sussman JL, Futerman AH (2010) Molecular basis of reduced glucosylceramidase activity in the most common Gaucher disease mutant, N370S. J Biol Chem 285(53):42105\u201342114","journal-title":"J Biol Chem"},{"issue":"7","key":"20_CR002051","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1023\/B:BOLI.0000005623.60471.51","volume":"26","author":"GM Pastores","year":"2003","unstructured":"Pastores GM, Barnett NL, Bathan P, Kolodny EH (2003) A neurological symptom survey of patients with type I Gaucher disease. J Inherit Metab Dis 26(7):641\u2013645","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"20_CR002052","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1023\/A:1005622001239","volume":"23","author":"D Pelled","year":"2000","unstructured":"Pelled D, Shogomori H, Futerman AH (2000) The increased sensitivity of neurons with elevated glucocerebroside to neurotoxic agents can be reversed by imiglucerase. J Inherit Metab Dis 23(2):175\u2013184","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"20_CR002053","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.nbd.2004.09.004","volume":"18","author":"D Pelled","year":"2005","unstructured":"Pelled D, Trajkovic-Bodennec S, Lloyd-Evans E, Sidransky E, Schiffmann R, Futerman AH (2005) Enhanced calcium release in the acute neuronopathic form of Gaucher disease. Neurobiol Dis 18(1):83\u201388","journal-title":"Neurobiol Dis"},{"issue":"457","key":"20_CR002054","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1651-2227.2008.00656.x","volume":"97","author":"FM Platt","year":"2008","unstructured":"Platt FM, Jeyakumar M (2008) Substrate reduction therapy. Acta Paediatr Suppl 97(457):88\u201393","journal-title":"Acta Paediatr Suppl"},{"issue":"4","key":"20_CR002055","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.bbamcr.2008.08.009","volume":"1793","author":"FM Platt","year":"2009","unstructured":"Platt FM, Lachmann RH (2009) Treating lysosomal storage disorders: current practice and future prospects. Biochim Biophys Acta 1793(4):737\u2013745","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"20_CR002056","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10545-010-9093-7","volume":"33","author":"H Poupetova","year":"2010","unstructured":"Poupetova H, Ledvinova J, Berna L, Dvorakova L, Kozich V, Elleder M (2010) The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations. J Inherit Metab Dis 33(4):387\u2013396","journal-title":"J Inherit Metab Dis"},{"issue":"25","key":"20_CR002057","doi-asserted-by":"publisher","first-page":"23815","DOI":"10.1074\/jbc.M502799200","volume":"280","author":"L Premkumar","year":"2005","unstructured":"Premkumar L, Sawkar AR, Boldin-Adamsky S, Toker L, Silman I, Kelly JW et al (2005) X-ray structure of human acid-beta-glucosidase covalently bound to conduritol-B-epoxide. Implications for Gaucher disease. J Biol Chem 280(25):23815\u201323819","journal-title":"J Biol Chem"},{"issue":"24","key":"20_CR002058","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1212\/01.wnl.0000314657.92762.0f","volume":"70","author":"E Rogaeva","year":"2008","unstructured":"Rogaeva E, Hardy J (2008) Gaucher and Parkinson diseases: unexpectedly related. Neurology 70(24):2272\u20132273","journal-title":"Neurology"},{"issue":"10","key":"20_CR002059","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1002\/mds.23046","volume":"25","author":"R Saunders-Pullman","year":"2010","unstructured":"Saunders-Pullman R, Hagenah J, Dhawan V, Stanley K, Pastores G, Sathe S et al (2010) Gaucher disease ascertained through a Parkinson\u02bcs center: imaging and clinical characterization. Mov Disord 25(10):1364\u20131372","journal-title":"Mov Disord"},{"issue":"10","key":"20_CR002060","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s00018-005-5437-0","volume":"63","author":"AR Sawkar","year":"2006","unstructured":"Sawkar AR, D\u02bcHaeze W, Kelly JW (2006) Therapeutic strategies to ameliorate lysosomal storage disorders\u2013a focus on Gaucher disease. Cell Mol Life Sci 63(10):1179\u20131192","journal-title":"Cell Mol Life Sci"},{"key":"20_CR002061","first-page":"175","volume-title":"Gaucher disease","author":"R Schiffmann","year":"2007","unstructured":"Schiffmann R, Vellodi A (2007) Neuoronopathic Gaucher disease. In: Futerman AH, Zimran A (eds) Gaucher disease. CRC, Boca Raton, pp 175\u2013196"},{"issue":"9","key":"20_CR002062","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1002\/mds.23774","volume":"26","author":"T Shachar","year":"2011","unstructured":"Shachar T, Lo Bianco C, Recchia A, Wiessner C, Raas-Rothschild A, Futerman AH (2011) Lysosomal storage disorders and Parkinson\u02bcs disease: Gaucher disease and beyond. Mov Disord 26(9):1593\u20131604","journal-title":"Mov Disord"},{"issue":"1","key":"20_CR002063","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1203\/00006450-199601000-00020","volume":"39","author":"E Sidransky","year":"1996","unstructured":"Sidransky E, Fartasch M, Lee RE, Metlay LA, Abella S, Zimran A et al (1996) Epidermal abnormalities may distinguish type 2 from type 1 and type 3 of Gaucher disease. Pediatr Res 39(1):134\u2013141","journal-title":"Pediatr Res"},{"issue":"17","key":"20_CR002064","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","volume":"361","author":"E Sidransky","year":"2009","unstructured":"Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, Barbosa ER et al (2009) Multicenter analysis of glucocerebrosidase mutations in Parkinson\u02bcs disease. N Engl J Med 361(17):1651\u20131661","journal-title":"N Engl J Med"},{"issue":"5","key":"20_CR002065","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/j.1471-4159.1978.tb12395.x","volume":"30","author":"MC Stephens","year":"1978","unstructured":"Stephens MC, Bernatsky A, Burachinsky V, Legler G, Kanfer JN (1978) The Gaucher mouse: differential action of conduritol B epoxide and reversibility of its effects. J Neurochem 30(5):1023\u20131027","journal-title":"J Neurochem"},{"issue":"6","key":"20_CR002066","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/hmg\/ddp580","volume":"19","author":"Y Sun","year":"2010","unstructured":"Sun Y, Liou B, Ran H, Skelton MR, Williams MT, Vorhees CV et al (2010) Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits. Hum Mol Genet 19(6):1088\u20131097","journal-title":"Hum Mol Genet"},{"issue":"4","key":"20_CR002067","doi-asserted-by":"publisher","first-page":"e19037","DOI":"10.1371\/journal.pone.0019037","volume":"6","author":"Y Sun","year":"2011","unstructured":"Sun Y, Ran H, Liou B, Quinn B, Zamzow M, Zhang W et al (2011) Isofagomine in vivo effects in a neuronopathic Gaucher disease mouse. PLoS One 6(4):e19037","journal-title":"PLoS One"},{"issue":"9","key":"20_CR002068","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1177\/08830738030180090201","volume":"18","author":"K Suzuki","year":"2003","unstructured":"Suzuki K (2003) Globoid cell leukodystrophy (Krabbe\u02bcs disease): update. J Child Neurol 18(9):595\u2013603","journal-title":"J Child Neurol"},{"issue":"2","key":"20_CR002069","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S1096-7192(03)00071-4","volume":"79","author":"N Tayebi","year":"2003","unstructured":"Tayebi N, Walker J, Stubblefield B, Orvisky E, LaMarca ME, Wong K et al (2003) Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Mol Genet Metab 79(2):104\u2013109","journal-title":"Mol Genet Metab"},{"issue":"6377","key":"20_CR002070","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/357407a0","volume":"357","author":"VL Tybulewicz","year":"1992","unstructured":"Tybulewicz VL, Tremblay ML, LaMarca ME, Willemsen R, Stubblefield BK, Winfield S et al (1992) Animal model of Gaucher\u02bcs disease from targeted disruption of the mouse glucocerebrosidase gene. Nature 357(6377):407\u2013410","journal-title":"Nature"},{"issue":"3","key":"20_CR002071","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s11910-010-0102-x","volume":"10","author":"A Velayati","year":"2010","unstructured":"Velayati A, Yu WH, Sidransky E (2010) The role of glucocerebrosidase mutations in Parkinson disease and Lewy body disorders. Curr Neurol Neurosci Rep 10(3):190\u2013198","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"5","key":"20_CR002072","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s10545-009-1164-2","volume":"32","author":"A Vellodi","year":"2009","unstructured":"Vellodi A, Tylki-Szymanska A, Davies EH, Kolodny E, Bembi B, Collin-Histed T et al (2009) Management of neuronopathic Gaucher disease: revised recommendations. J Inherit Metab Dis 32(5):660\u2013664","journal-title":"J Inherit Metab Dis"},{"issue":"18","key":"20_CR002073","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1093\/hmg\/ddq273","volume":"19","author":"EB Vitner","year":"2010","unstructured":"Vitner EB, Dekel H, Zigdon H, Shachar T, Farfel-Becker T, Eilam R et al (2010a) Altered expression and distribution of cathepsins in neuronopathic forms of Gaucher disease and in other sphingolipidoses. Hum Mol Genet 19(18):3583\u20133590","journal-title":"Hum Mol Genet"},{"issue":"27","key":"20_CR002074","doi-asserted-by":"publisher","first-page":"20423","DOI":"10.1074\/jbc.R110.134452","volume":"285","author":"EB Vitner","year":"2010","unstructured":"Vitner EB, Platt FM, Futerman AH (2010b) Common and uncommon pathogenic cascades in lysosomal storage diseases. J Biol Chem 285(27):20423\u201320427","journal-title":"J Biol Chem"},{"key":"20_CR002075","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1093\/brain\/aws095","volume":"135","author":"EB Vitner","year":"2012","unstructured":"Vitner EB, Farfel-Becker T, Eilam R, Biton I, Futerman AH (2012) Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher disease. Brain 135:1724\u20131735","journal-title":"Brain"},{"issue":"4","key":"20_CR002076","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/hmg\/ddm324","volume":"17","author":"H Wei","year":"2008","unstructured":"Wei H, Kim SJ, Zhang Z, Tsai PC, Wisniewski KE, Mukherjee AB (2008) ER and oxidative stresses are common mediators of apoptosis in both neurodegenerative and non-neurodegenerative lysosomal storage disorders and are alleviated by chemical chaperones. Hum Mol Genet 17(4):469\u2013477","journal-title":"Hum Mol Genet"},{"issue":"1","key":"20_CR002077","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1074\/jbc.M110.150433","volume":"286","author":"RR Wei","year":"2011","unstructured":"Wei RR, Hughes H, Boucher S, Bird JJ, Guziewicz N, Van Patten SM et al (2011) X-ray and biochemical analysis of N370S mutant human acid beta-glucosidase. J Biol Chem 286(1):299\u2013308","journal-title":"J Biol Chem"},{"issue":"2\u20133","key":"20_CR002078","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/BF02962142","volume":"24","author":"R Willemsen","year":"1995","unstructured":"Willemsen R, Tybulewicz V, Sidransky E, Eliason WK, Martin BM, LaMarca ME et al (1995) A biochemical and ultrastructural evaluation of the type 2 Gaucher mouse. Mol Chem Neuropathol 24(2\u20133):179\u2013192","journal-title":"Mol Chem Neuropathol"},{"issue":"3","key":"20_CR002079","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ymgme.2004.04.011","volume":"82","author":"K Wong","year":"2004","unstructured":"Wong K, Sidransky E, Verma A, Mixon T, Sandberg GD, Wakefield LK et al (2004) Neuropathology provides clues to the pathophysiology of Gaucher disease. Mol Genet Metab 82(3):192\u2013207","journal-title":"Mol Genet Metab"},{"issue":"4","key":"20_CR002080","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ymgme.2010.12.014","volume":"102","author":"YH Xu","year":"2011","unstructured":"Xu YH, Sun Y, Ran H, Quinn B, Witte D, Grabowski GA (2011) Accumulation and distribution of alpha-synuclein and ubiquitin in the CNS of Gaucher disease mouse models. Mol Genet Metab 102(4):436\u2013447","journal-title":"Mol Genet Metab"},{"issue":"32","key":"20_CR002081","doi-asserted-by":"publisher","first-page":"28080","DOI":"10.1074\/jbc.M111.237859","volume":"286","author":"TL Yap","year":"2011","unstructured":"Yap TL, Gruschus JM, Velayati A, Westbroek W, Goldin E, Moaven N et al (2011) Alpha-synuclein interacts with Glucocerebrosidase providing a molecular link between Parkinson and Gaucher diseases. J Biol Chem 286(32):28080\u201328088","journal-title":"J Biol Chem"},{"issue":"2","key":"20_CR002082","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ymgme.2007.03.004","volume":"91","author":"SG Ziegler","year":"2007","unstructured":"Ziegler SG, Eblan MJ, Gutti U, Hruska KS, Stubblefield BK, Goker-Alpan O et al (2007) Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease. Mol Genet Metab 91(2):195\u2013200","journal-title":"Mol Genet Metab"}],"container-title":["Handbook of Experimental Pharmacology","Sphingolipids in Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-7091-1511-4_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T14:10:34Z","timestamp":1675951834000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-7091-1511-4_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"ISBN":["9783709115107","9783709115114"],"references-count":82,"URL":"https:\/\/doi.org\/10.1007\/978-3-7091-1511-4_20","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"type":"print","value":"0171-2004"},{"type":"electronic","value":"1865-0325"}],"subject":[],"published":{"date-parts":[[2013]]},"assertion":[{"value":"7 March 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}